Cutibacterium avidum caused a liver abscess after transarterial chemoembolization for hepatocellular carcinoma.

J Infect ChemotherAug 18, 2026 (epub)

Takashi Koyama, Kei Furui Ebisawa, Goh Ohji et al.

✦ AI-curated · Sources linked

Case in brief

An 83-year-old man developed a liver abscess following transarterial chemoembolization for recurrent hepatocellular carcinoma, presenting with fever 10 days post-procedure. Imaging revealed a fluid collection, and initial antibiotic therapy was ineffective. Subsequent drainage of the abscess identified Cutibacterium avidum, leading to symptom resolution and no recurrence reported.

What made this case unusual

This case highlights a liver abscess caused by Cutibacterium avidum, a rare organism not previously reported in this context, following a common oncological procedure.

Diagnostic / clinical pearl

Clinicians should consider atypical pathogens like Cutibacterium avidum in cases of liver abscess after transarterial chemoembolization, especially when standard treatments fail.

Why it matters

Recognizing the potential for unusual organisms in post-procedural infections can guide more effective management strategies and improve patient outcomes.

Source

Published in J Infect Chemother. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.